Ardent Health Partners (NYSE:ARDT) Price Target Lowered to $18.00 at Mizuho

Ardent Health Partners (NYSE:ARDT - Get Free Report) had its target price decreased by investment analysts at Mizuho from $19.00 to $18.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Mizuho's target price would suggest a potential upside of 48.27% from the company's previous close.

Several other equities research analysts have also recently commented on the company. Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Royal Bank of Canada dropped their price objective on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Tuesday, March 4th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Stephens reissued an "overweight" rating and set a $22.00 price target on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Finally, Morgan Stanley reduced their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Two analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Ardent Health Partners has a consensus rating of "Buy" and an average target price of $20.58.

Remove Ads

Ardent Health Partners Stock Performance

Ardent Health Partners stock traded up $0.36 on Wednesday, reaching $12.14. The company's stock had a trading volume of 120,678 shares, compared to its average volume of 404,788. The business's fifty day moving average price is $13.86 and its 200 day moving average price is $15.74. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a twelve month low of $11.60 and a twelve month high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. As a group, equities research analysts forecast that Ardent Health Partners will post 1.23 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Ardent Health Partners in the 4th quarter valued at about $27,000. US Bancorp DE bought a new position in Ardent Health Partners during the 4th quarter worth $31,000. R Squared Ltd acquired a new position in shares of Ardent Health Partners during the 4th quarter worth approximately $37,000. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners during the third quarter worth approximately $42,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Ardent Health Partners in the fourth quarter valued at approximately $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.